Tetraphase Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company using its proprietary chemistry technology creates novel antibiotics for serious and life-threatening multi-drug resistant infections.


Updates from The Motley Fool

Latest updates on Tetraphase Pharmaceuticals from Fool.com.


Stock Performance

View Interactive TTPH Charts
Sponsored by

Key Data Points

Primary metrics and data points about Tetraphase Pharmaceuticals.
Current Price: $8.16
Prev Close: $8.36
Open: $8.30
Bid: $8.17
Ask: $8.18
Day's Range: $8.15 - $8.59
52wk Range: $3.11 - $8.69
Volume: 328,982
Avg Vol 707,418
Market Cap: $302M
P/E (ttm): -3.96
EPS (ttm): ($2.11)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Tetraphase Pharmaceuticals.
CAPS Rating 4 out of 5
 
49 Outperform
3 Underperform
CAPS All Stars
 
15 Outperform
0 Underperform

How do you think Tetraphase Pharmaceuticals will perform against the market?



You pick for Tetraphase Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Tetraphase Pharmaceuticals.

Tetraphase Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company using its proprietary chemistry technology creates novel antibiotics for serious and life-threatening multi-drug resistant infections.

  • Exchange: NASDAQ